Action Type | Duplicate Counter | Action Date | Document Type | Application Document ID | Sequence Number | Document Title | Document URL | Document Date |
AP | 0 | 4/30/2003 | N | 5580 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021503lbl.pdf
| 5/6/2003 |
AP | 0 | 4/30/2003 | N | 5743 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21503ltr.pdf
| 5/29/2003 |
AP | 0 | 4/30/2003 | N | 13285 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021503s000_ViraceptTOC.cfm
| 12/16/2005 |
AP | 0 | 3/19/2004 | SE5 | 8011 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20778se5-022,20779se5-042,21503se5-001ltr.pdf
| 3/24/2004 |
AP | 0 | 3/19/2004 | SE5 | 8248 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20778se5-022,20779se5-042,21503se5-001_viracept_lbl.pdf
| 4/5/2004 |
AP | 0 | 3/19/2004 | SE5 | 17543 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021503_S001_VIRACEPT.pdf
| 8/6/2007 |
AP | 0 | 8/22/2003 | SLR | 6553 | 002 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20778slr020,20779slr041,21503slr002_viracept_lbl.pdf
| 8/28/2003 |
AP | 0 | 8/22/2003 | SLR | 6583 | 002 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20778slr020,20779slr041,21503slr002ltr.pdf
| 8/29/2003 |
AP | 0 | 6/4/2004 | SLR | 9093 | 003 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20778slr003,20779slr044,21503slr003ltr.pdf
| 6/7/2004 |
AP | 0 | 6/4/2004 | SLR | 9128 | 003 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20778slr003,20779slr044,21503slr003_viracept_lbl.pdf
| 6/7/2004 |
AP | 0 | 9/28/2005 | SLR | 12825 | 006 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021503s006lbl.pdf
| 9/30/2005 |
AP | 0 | 9/28/2005 | SLR | 12931 | 006 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020778s024,020779s045,021503s006ltr.pdf
| 10/20/2005 |
AP | 0 | 9/28/2005 | SLR | 17544 | 006 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021503_S006_VIRACEPT.pdf
| 8/6/2007 |
AP | 0 | 12/22/2006 | SLR | 15508 | 007 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020778s025,020779s046,021503s007lbl.pdf
| 12/28/2006 |
AP | 0 | 12/22/2006 | SLR | 15613 | 007 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020778s025, 020779s046, 021503s007ltr.pdf
| 1/8/2007 |
AP | 0 | 7/31/2007 | SLR | 17453 | 009 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020778s027,020779s048,021503s009lbl.pdf
| 8/2/2007 |
AP | 0 | 2/13/2008 | SLR | 19097 | 011 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021503s011ltr.pdf
| 2/14/2008 |
AP | 0 | 2/13/2008 | SLR | 19103 | 011 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020778s029,020779s050,021503s011lbl.pdf
| 2/14/2008 |
AP | 0 | 11/25/2008 | SLR | 21286 | 014 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020778s032, 020779s053, 021503s014ltr.pdf
| 11/26/2008 |
AP | 0 | 4/26/2010 | SLR | 25377 | 015 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020778s033,s034,020779s054,s055,021503s015,s016ltr.pdf
| 4/28/2010 |
AP | 0 | 4/26/2010 | SLR | 25416 | 015 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020778s033s034,020779s054s055,021503s015s016lbl.pdf
| 5/3/2010 |
AP | 0 | 4/26/2010 | SLR | 25376 | 016 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020778s033,s034,020779s054,s055,021503s015,s016ltr.pdf
| 4/28/2010 |
AP | 0 | 4/26/2010 | SLR | 25417 | 016 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020778s033s034,020779s054s055,021503s015s016lbl.pdf
| 5/3/2010 |
AP | 0 | 2/25/2011 | SLR | 27987 | 017 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020778s035,020779s056,021503s017ltr.pdf
| 2/28/2011 |
AP | 0 | 2/25/2011 | SLR | 28047 | 017 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020778s035,020779s056,021503s017lbl.pdf
| 3/4/2011 |
AP | 0 | 4/6/2012 | SLR | 32383 | 018 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020778s036,020779s057,021503s018lbl.pdf
| 4/9/2012 |
AP | 0 | 4/6/2012 | SLR | 32398 | 018 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020778Orig1s036,020779Orig1s057,021503Orig1s018ltr.pdf
| 4/11/2012 |
AP | 0 | 2/17/2012 | SLR | 31882 | 020 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020778s037,020779s058,021503s020lbl.pdf
| 2/24/2012 |
AP | 0 | 2/17/2012 | SLR | 31889 | 020 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020778s037,020779s058,021503s020ltr.pdf
| 2/27/2012 |
AP | 0 | 5/28/2013 | SLR | 36170 | 021 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020778Orig1s038,020779Orig1s059,021503Orig1s021ltr.pdf
| 5/31/2013 |
AP | 0 | 5/28/2013 | SLR | 36220 | 021 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020778s038,020779s059,021503s021lbl.pdf
| 6/4/2013 |
AP | 0 | 3/27/2015 | SLR | 42328 | 023 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/20778Orig1s040,20779Orig1s061,21503Orig1s023ltr.pdf
| 3/31/2015 |
AP | 0 | 3/27/2015 | SLR | 42468 | 023 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020778s040,020779s061,021503s023lbl.pdf
| 4/7/2015 |
AP | 0 | 9/15/2016 | SLR | 47082 | 024 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021503Orig1s024,020778Orig1s041,020779Orig1s062ltr.pdf
| 9/20/2016 |
AP | 0 | 9/15/2016 | SLR | 47105 | 024 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020778s041,020779s062,021503s024lbl.pdf
| 9/20/2016 |